Aptose Biosciences Inc (APTO) Annual Balance Sheets

Annual · GAAP · USD millions
Access APTO quarterly Balance Sheets →
The data below summarizes Aptose Biosciences Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.94
Restricted Cash and Cash Equivalents, Current3.16
Short-term Investments, Total0.00
Cash & Short-term Investments3.00
Other Current Assets0.00
Prepaid Expense, Current AS2.21
Total Current Assets6.45
Equipment/Property/Plant Net0.00
Tax Assets, Noncurrent105.97
Other Assets, Noncurrent0.00
Restricted Cash Equivalents Current0.56
Operating Lease Right Of Use Asset0.57
Total Assets10.01
Liabilities
Accounts Payable, Current AC2.91
Accrued Liabilities, Current AC6.20
Other Liabilities, Current0.00
Total Current Liabilities9.31
Total Long-term Debt0.00
Discontinued Operation, Noncurrent1.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Operating Lease Liability Noncurrent0.19
Loan Payable To Related Parties Non Current10.02
Total Liabilities37.18
Stockholders' Equity
Common Stock Value459.77
Additional Paid In Capital Common Stock83.81
Retained Earnings / Accumulated Deficit-566.44
Accumulated Other Comprehensive Income-4.32
Other Equity-4.32
Common Stockholder's Equity-27.17
Total Stockholder's Equity-27.17
Liabilities & Stockholder's Equity10.01
4 historic quarters locked

Sign in to unlock the full Aptose Biosciences Inc balance sheet history.

About Aptose Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-135012

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.